News

19. 4. 2024

A new strategy to determine whether nanomedicines will be effective for a patient

Scientists from the Institute of Macromolecular Chemistry of the CAS, led by Tomáš Etrych, whose research group is part of the NIRC, have been involved in developing a strategy to determine whether treatment with advanced forms of nanomedicines will be of significant benefit to patients or remain without effect.